Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy

Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy

Triple negative breast cancer (TNBC) cells are resistant to hormonal/targeted therapies. This study aims to investigate epigenetic differences between TNBC and other types of breast cancer and the effect of epigenetic modulation on the response of TNBC cells to hormonal therapy. Thus, we investigate...

Full description

Bibliographic Details
Main Authors:	Wafaa S Ramadan, Cijo George Vazhappilly, Ekram M Saleh, Varsha Menon, Aya M AlAzawi, Ahmed T El-Serafi, Wael Mansour, Raafat El-Awady
Format:	Article
Language:	English
Published:	MDPI AG 2018-12-01
Series:	Cancers
Subjects:	triple negative breast cancer estrogen receptor alpha human epidermal growth factor receptor-2 epigenetics suberoylanilide hydroxamic acid 2′-deoxy-5-azacytidine tamoxifen
Online Access:	http://www.mdpi.com/2072-6694/11/1/13

Similar Items

Design, Synthesis and Biological Evaluation of Hydroxamic Acid Derivatives as Potential High Density Lipoprotein (HDL) Receptor CLA-1 Up-Regulating Agents
by: Yu Du, et al.
Published: (2011-11-01)

Changes in the Expression of TBP-2 in Response to Histone Deacetylase Inhibitor Treatment in Human Endometrial Cells
by: Hye In Kim, et al.
Published: (2021-01-01)

Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells
by: Sonia Abou Najem, et al.
Published: (2019-11-01)

Application of Electric Cell-Substrate Impedance Sensing to Investigate the Cytotoxic Effects of Andrographolide on U-87 MG Glioblastoma Cell Migration and Apoptosis
by: Sheng-Po Chiu, et al.
Published: (2019-05-01)

Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses
by: Manish Bodas, et al.
Published: (2018-01-01)

ING5‐mediated antineuroblastoma effects of suberoylanilide hydroxamic acid
by: Ji‐cheng Wu, et al.
Published: (2018-09-01)

In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model
by: Thiemann Markus, et al.
Published: (2012-03-01)

Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines
by: Yin-Gi Jang, et al.
Published: (2018-11-01)

p53-Mediated Molecular Control of Autophagy in Tumor Cells
by: Maria Mrakovcic, et al.
Published: (2018-03-01)

Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines
by: Kulozik Andreas E, et al.
Published: (2011-09-01)

HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes
by: Jaspreet Singh, et al.
Published: (2011-11-01)

Histone Deacetylase Inhibitor SAHA Improves High Salinity Tolerance Associated with Hyperacetylation-Enhancing Expression of Ion Homeostasis-Related Genes in Cotton
by: Shibin He, et al.
Published: (2020-09-01)

Antimicrobial Metabolites Produced by Penicillium mallochii CCH01 Isolated From the Gut of Ectropis oblique, Cultivated in the Presence of a Histone Deacetylase Inhibitor
by: Shuxiang Zhang, et al.
Published: (2019-10-01)

Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer
by: Xiang Xu, et al.
Published: (2017-01-01)

Dissection of Anti-tumor Activity of Histone Deacetylase Inhibitor SAHA in Nasopharyngeal Carcinoma Cells via Quantitative Phosphoproteomics
by: Huichao Huang, et al.
Published: (2020-11-01)

Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure
by: Xiaodi Qiu, et al.
Published: (2019-02-01)

Vorinostat (SAHA) and Breast Cancer: An Overview
by: Anna Wawruszak, et al.
Published: (2021-09-01)

Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in human pancreatic cancer
by: Nelson S. Yee, et al.
Published: (2012-02-01)

Ligand- and Phosphorylation-dependent Modulation of Estrogen Reeptor Target Gene Expression
by: Koterba, Kristen L.
Published: (2006)

Outcome After Azacitidine Treatment in Patients with High-Risk Myeolodysplastic Syndrome, Chronic Myelomonocytic Leukemia Type 2 and Acute Myeloid Leukemia – A Single Center Experience (Preliminary Data)
by: Varbanova V., et al.
Published: (2020-11-01)

NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells
by: Jih-Tung Pai, et al.
Published: (2015-05-01)

Suberoylanilide hydroxamic acid suppresses hepatic stellate cells activation by HMGB1 dependent reduction of NF-κB1
by: Wenwen Wang, et al.
Published: (2015-11-01)

Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer
by: Javier A. Menendez, et al.
Published: (2021-03-01)

Mécanismes de résistance à l’Azacytidine dans les syndromes myélodysplasiques et les leucémies aiguës myéloïdes : implication de l’autophagie médiée par les chaperonnes et nouvelles approches thérapeutiques
by: Dubois, Alix
Published: (2016)

Histone Deacetylase Inhibition Downregulates Collagen 3A1 in Fibrotic Lung Fibroblasts
by: Victor J. Thannickal, et al.
Published: (2013-09-01)

Synthesis Of 2-Deoxy-1-Thioglycosides And Establishing Their Efficient Glycosyl Donor Properties To Prepare Aryl 2-Deoxy Glycosides And 2-Deoxy Oligosaccharides
by: Paul, Somak
Published: (2010)

Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
by: Pin Gao, et al.
Published: (2018-09-01)

Pathways to Endocrine Therapy Resistance in Breast Cancer
by: Md. Moquitul Haque, et al.
Published: (2019-08-01)

Analysis of advanced non-small cell lung cancer course during high dose antiestrogen therapy use in complex chemoradiotherapy treatment of patients
by: A. V. Kadzhoian
Published: (2014-12-01)

Metabolically engineered recombinant Saccharomyces cerevisiae for the production of 2-Deoxy-scyllo-inosose (2-DOI)
by: Ahmed J. Al-Fahad, et al.
Published: (2020-12-01)

DNMT Inhibitors Increase Methylation in the Cancer Genome
by: Anil K. Giri, et al.
Published: (2019-04-01)

HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
by: Anja Kathrin Wege, et al.
Published: (2018-11-01)

5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Marianna Criscuolo, et al.
Published: (2011-01-01)

5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Mariangela Greco, et al.
Published: (2011-03-01)

Synthesis of the Novel 4,4?- and 6,6?- Dihydroxamic - 2,2?-Bipyridines and Improved Routes to 4,4?- and 6,6?- Substituted 2,2?-Bipyridines and Mono-N-Oxide-2,2?-Bipyridine
by: Donnici Claudio Luis, et al.
Published: (1998-01-01)

Tamoxifen and Endometrial Cancer: A Janus-Headed Drug
by: Günter Emons, et al.
Published: (2020-09-01)

The potential influence of breast cancer estrogen receptors’ distribution on active DNA demethylation
by: Kinga Linowiecka, et al.
Published: (2019-05-01)

Enhanced Biosynthesis of 2-Deoxy-scyllo-inosose in Metabolically Engineered Bacillus subtilis Recombinants
by: Joo Hyun Lim, et al.
Published: (2018-09-01)

Induction of DNA damage, apoptosis and cell cycle perturbation mediate cytotoxic activity of new 5-aminosalicylate–4-thiazolinone hybrid derivatives
by: Wafaa S Ramadan, et al.
Published: (2020-11-01)

Implication des facteurs épigénétiques dans l'épileptogenèse et les déficits cognitifs associés à l'épilepsie du lobe temporal
by: Siyoucef, Souhila Safia
Published: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b0jjls45p3io26iqp64vupkmth